- Home
- LEN vs KVUE Comparison
LEN vs KVUE Comparison
Compare LEN & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEN
- KVUE
- Stock Information
- Founded
- LEN 1954
- KVUE 2022
- Country
- LEN United States
- KVUE United States
- Employees
- LEN N/A
- KVUE N/A
- Industry
- LEN Homebuilding
- KVUE Specialty Chemicals
- Sector
- LEN Consumer Discretionary
- KVUE Consumer Discretionary
- Exchange
- LEN Nasdaq
- KVUE Nasdaq
- Market Cap
- LEN 49.0B
- KVUE 35.8B
- IPO Year
- LEN N/A
- KVUE 2023
- Fundamental
- Price
- LEN $179.42
- KVUE $22.86
- Analyst Decision
- LEN Buy
- KVUE Buy
- Analyst Count
- LEN 17
- KVUE 12
- Target Price
- LEN $176.14
- KVUE $22.45
- AVG Volume (30 Days)
- LEN 1.4M
- KVUE 13.3M
- Earning Date
- LEN 09-16-2024
- KVUE 10-24-2024
- Dividend Yield
- LEN 1.11%
- KVUE 3.59%
- EPS Growth
- LEN 0.35
- KVUE N/A
- EPS
- LEN 14.73
- KVUE 0.57
- Revenue
- LEN $35,776,308,000.00
- KVUE $15,475,000,000.00
- Revenue This Year
- LEN $4.16
- KVUE $3.65
- Revenue Next Year
- LEN $8.05
- KVUE $3.47
- P/E Ratio
- LEN $12.18
- KVUE $39.77
- Revenue Growth
- LEN 6.34
- KVUE 0.36
- 52 Week Low
- LEN $102.90
- KVUE $17.67
- 52 Week High
- LEN $186.60
- KVUE $23.00
- Technical
- Relative Strength Index (RSI)
- LEN 57.31
- KVUE 77.04
- Support Level
- LEN $175.50
- KVUE $21.65
- Resistance Level
- LEN $183.94
- KVUE $22.09
- Average True Range (ATR)
- LEN 3.96
- KVUE 0.38
- MACD
- LEN -0.56
- KVUE 0.01
- Stochastic Oscillator
- LEN 48.31
- KVUE 92.09
About LEN Lennar Corporation
Lennar is one of the largest public homebuilders in the United States. The company's homebuilding operations target first-time, move-up, and active adult homebuyers mainly under the Lennar brand name. Lennar's financial-services segment provides mortgage financing and related services to its homebuyers. Miami-based Lennar is also involved in multifamily and single-family for rent construction and has invested in numerous housing-related technology startups.
About KVUE Kenvue Inc.
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.